Two doses were not enough: Pfizer suggests giving children under 5 three COVID-19 vaccinations - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Two doses were not enough: Pfizer suggests giving children under 5 three vaccinations against COVID-19

Early analysis showed two doses of COVID-19 vaccine were ineffective in some young children, Pfizer said. The company plans to make adjustments to an ongoing study to test the efficacy of a third dose. Writes about it NBC New York.

Photo: Shutterstock

“Compared with people aged 16 to 25 years, who were found to be highly effective, noninferiority was found for the 6 to 24 month group, but not for the 2 to 5 year group,” Pfizer said in a statement.

The company will now consider a third dose two months after the second in children ages 6 months to 5 years.

Pfizer said that if the three-dose regime works, it plans to apply for an emergency use authorization to regulators in the first half of next year.

Pfizer's children's version of the vaccine is already available for children ages 5 to 11, accounting for a third of the dose given to everyone else 12 and older. Independent.

On the subject: Pfizer has developed pills for COVID-19: their effectiveness is almost 90%

For children under 5, Pfizer is testing an even lower dose, just 3 micrograms, or a tenth of the adult dose.

The researchers analyzed a subgroup of children in the study one month after taking the second dose to see if they developed antibody levels similar to those of adolescents and young adults who received the vaccine.

Toddlers under 2 years of age had similar antibody levels, but the immune response was lower in children 2 to 4 years old, said Pfizer vaccine research leader Katrin Jansen.

No security issues were found in the study, according to a company spokesman.

You may be interested in: top New York news, stories of our immigrants and helpful tips about life in the Big Apple - read it all on ForumDaily New York

Jansen cited data showing that booster shots for people 16 and older restore strong defenses. A spike in immunity is taking place, which scientists hope will help ward off the new omicron strain.

The company, among other things, is preparing to test a booster for children aged 5 to 11, who are currently receiving only two-dose vaccinations. And they are testing different booster doses for teens.

Jansen noted that if additional testing is successful, "we will have a consistent approach to vaccination with three doses for all ages."

Read also on ForumDaily:

Study: COVID-19 booster shots are not just useless, they can even harm

Scientists in Philadelphia Create Antique Chewing Gum

How and how much you can earn from participating in clinical trials

USA approved vaccination against COVID-19 for children 5-11 years old: when to expect vaccinations and whether to fear adverse reactions

vaccine Pfizer World Special Projects COVID-19
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1084 requests in 1,081 seconds.